Vir Biotechnology, Inc. - VIR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 02, 2026 | — | S | D | 3,200.0 | 9.45 | 30,240.0 | 21,216.0 | View | |
| Jun 02, 2026 | SVP, Chief Accounting Officer | S | D | 379.0 | 9.45 | 3,581.55 | 61,902.0 | View | |
| May 28, 2026 | — | A | A | 16,000.0 | 0.0 | 0.0 | 16,000.0 | View | |
| May 28, 2026 | — | A | A | 8,000.0 | 0.0 | 0.0 | 39,806.0 | View | |
| May 28, 2026 | — | A | A | 16,000.0 | 0.0 | 0.0 | 16,000.0 | View | |
| May 28, 2026 | — | A | A | 8,000.0 | 0.0 | 0.0 | 24,416.0 | View | |
| May 28, 2026 | — | A | A | 16,000.0 | 0.0 | 0.0 | 16,000.0 | View | |
| May 28, 2026 | — | A | A | 8,000.0 | 0.0 | 0.0 | 48,656.0 | View | |
| May 28, 2026 | — | A | A | 16,000.0 | 0.0 | 0.0 | 16,000.0 | View | |
| May 28, 2026 | — | A | A | 8,000.0 | 0.0 | 0.0 | 39,806.0 | View | |
| May 28, 2026 | — | A | A | 16,000.0 | 0.0 | 0.0 | 16,000.0 | View | |
| May 28, 2026 | — | A | A | 8,000.0 | 0.0 | 0.0 | 32,000.0 | View | |
| May 28, 2026 | — | A | A | 16,000.0 | 0.0 | 0.0 | 16,000.0 | View | |
| May 28, 2026 | — | A | A | 8,000.0 | 0.0 | 0.0 | 21,333.0 | View | |
| May 04, 2026 | — | S | D | 22,000.0 | 10.0466 | 221,025.2 | 1,078,391.0 | View | |
| Apr 30, 2026 | President and CEO | J | A | 233,532.0 | 0.0 | 0.0 | 286,650.0 | View | |
| Apr 30, 2026 | President and CEO | J | D | 233,532.0 | 0.0 | 0.0 | 714,613.0 | View | |
| Apr 07, 2026 | President and CEO | S | D | 72,559.0 | 9.156 | 664,350.2 | 948,145.0 | View | |
| Apr 02, 2026 | — | S | D | 22,000.0 | 9.0735 | 199,617.0 | 1,100,391.0 | View | |
| Mar 24, 2026 | SVP, Chief Accounting Officer | S | D | 7,711.0 | 9.12 | 70,324.32 | 61,902.0 | View | |
| Mar 23, 2026 | EVP & Chief Financial Officer | J | A | 2,500.0 | 0.0 | 0.0 | 2,500.0 | View | |
| Mar 23, 2026 | EVP & Chief Financial Officer | J | D | 2,500.0 | 0.0 | 0.0 | 160,115.0 | View | |
| Mar 03, 2026 | — | S | D | 200.0 | 9.98 | 1,996.0 | 1,122,391.0 | View | |
| Mar 03, 2026 | — | S | D | 21,800.0 | 9.5039 | 207,185.02 | 1,122,591.0 | View | |
| Feb 26, 2026 | EVP, General Counsel, Corp Sec | S | D | 13,700.0 | 9.82 | 134,534.0 | 112,982.0 | View | |
| Feb 26, 2026 | EVP, General Counsel, Corp Sec | S | D | 3,117.0 | 9.5326 | 29,713.11 | 126,682.0 | View | |
| Feb 26, 2026 | EVP and Chief Medical Officer | S | D | 1,889.0 | 9.82 | 18,549.98 | 154,024.0 | View | |
| Feb 26, 2026 | EVP and Chief Medical Officer | S | D | 1,616.0 | 9.5326 | 15,404.68 | 155,913.0 | View | |
| Feb 26, 2026 | EVP & Chief Financial Officer | S | D | 1,634.0 | 9.5326 | 15,576.27 | 162,615.0 | View | |
| Feb 26, 2026 | SVP, Chief Accounting Officer | S | D | 1,430.0 | 9.5326 | 13,631.62 | 69,613.0 | View | |
| Feb 26, 2026 | — | M | D | 42,377.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 26, 2026 | — | S | D | 200.0 | 10.26 | 2,052.0 | 1,144,391.0 | View | |
| Feb 26, 2026 | — | S | D | 42,177.0 | 9.7521 | 411,314.32 | 1,144,591.0 | View | |
| Feb 26, 2026 | — | M | A | 42,377.0 | 1.485 | 62,929.85 | 1,186,768.0 | View | |
| Feb 26, 2026 | Chief Executive Officer | S | D | 14,762.0 | 9.5326 | 140,720.24 | 1,020,704.0 | View | |
| Feb 24, 2026 | EVP, General Counsel, Corp Sec | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Feb 24, 2026 | EVP, General Counsel, Corp Sec | S | D | 4,445.0 | 7.4528 | 33,127.7 | 129,799.0 | View | |
| Feb 24, 2026 | EVP, General Counsel, Corp Sec | A | A | 55,000.0 | 0.0 | 0.0 | 134,244.0 | View | |
| Feb 24, 2026 | EVP and Chief Medical Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Feb 24, 2026 | EVP and Chief Medical Officer | S | D | 2,089.0 | 7.4528 | 15,568.9 | 157,529.0 | View | |
| Feb 24, 2026 | EVP and Chief Medical Officer | A | A | 55,000.0 | 0.0 | 0.0 | 159,618.0 | View | |
| Feb 24, 2026 | EVP & Chief Financial Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Feb 24, 2026 | EVP & Chief Financial Officer | S | D | 2,089.0 | 7.4528 | 15,568.9 | 164,249.0 | View | |
| Feb 24, 2026 | EVP & Chief Financial Officer | A | A | 55,000.0 | 0.0 | 0.0 | 166,338.0 | View | |
| Feb 24, 2026 | SVP, Chief Accounting Officer | A | A | 50,000.0 | 0.0 | 0.0 | 50,000.0 | View | |
| Feb 24, 2026 | SVP, Chief Accounting Officer | S | D | 1,829.0 | 7.4528 | 13,631.17 | 71,043.0 | View | |
| Feb 24, 2026 | SVP, Chief Accounting Officer | A | A | 25,000.0 | 0.0 | 0.0 | 72,872.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | A | A | 570,000.0 | 0.0 | 0.0 | 570,000.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | S | D | 19,039.0 | 7.4528 | 141,893.86 | 1,035,466.0 | View | |
| Feb 24, 2026 | Chief Executive Officer | A | A | 285,000.0 | 0.0 | 0.0 | 1,054,505.0 | View | |
| Feb 18, 2026 | SVP, Chief Accounting Officer | S | D | 1,530.0 | 7.79 | 11,918.7 | 47,872.0 | View | |
| Feb 03, 2026 | — | S | D | 22,000.0 | 7.7123 | 169,670.6 | 1,144,391.0 | View | |
| Jan 05, 2026 | — | S | D | 22,000.0 | 5.9265 | 130,383.0 | 1,166,391.0 | View |